CancerNavigator, Inc. — SEC Form D Filing
CancerNavigator, Inc. filed an SEC Form D on February 24, 2026, reporting $7.00M raised in Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- February 24, 2026
- Amount reported
- $7.00M
- Round stage
- Seed
- Industry
- Health Care
- Website
- https://www.cancernavigator.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Many cancer patients struggle to find the right expert care after diagnosis, which can lead to poor health outcomes.
Solution
CancerNavigator provides dedicated support through certified oncology nurses who guide patients to the best care options for their specific cancer type.
Why now
The need for effective cancer navigation is pressing as a significant percentage of patients do not connect with appropriate specialists.
Verdict
This cleared because investors recognized the pressing need for personalized cancer care navigation, not because the competitive landscape was well-defined. The implicit bet was on the company’s ability to provide differentiated patient support via certified oncology nurses, which could potentially disrupt existing healthcare delivery models. However, the limited upside lies in the dependency on health plan executives, whose budgeting constraints might restrict growth and scalability over time.
Source: SEC EDGAR Form D filing